Introduction: The cobas m 511 integrated hematology analyzer conducts a complete
| INTRODUC TI ON
Current automated hematology analyzers for the quantitative analysis of complete blood counts (CBC), white blood cell (WBC) differentials, reticulocytes, and nucleated red blood cell (NRBC) counts are methodically based on electrical impedance and optical or fluorescence flow cytometry. [1] [2] [3] Abnormal cases are flagged for review, necessitating preparation of a blood smear and a manual microscopic morphological differential count to identify the abnormalities. 4 As manual microscopy is time consuming, requires experienced medical staff, and is subject to significant variance, automated digital imaging systems were developed to address these issues for routine hematology diagnostics. [4] [5] [6] The cobas m 511 integrated hematology analyzer (Roche Diagnostics Operations Inc., Boston, MA, USA) combines a slide maker, slide stainer, digital image-based cell locator, cell counter, and cell classifier in one system. Unlike existing impedance-or flow cytometry-based automated hematology analyzers, all analyses with the cobas m 511 system are performed using microscope slides. Slides are prepared using a precision printing method from ethylenediaminetetraacetic acid (EDTA)-anticoagulated whole blood and stained automatically. 7 The CBC, automated differential, reticulocyte, and NRBC counts are performed using digital morphologic 
| MATERIAL S AND ME THODS
The study was conducted from June 2016 to January 2017. Sites started at different timepoints and the study duration at each site averaged 14 weeks including the reviews of the slides and images.
| Instrumentation and instrument setting
A nominal 1 μL of EDTA-anticoagulated whole blood was automatically printed on DigiMAC3 ® slides (Roche) by the cobas m 511 system using Bloodhound ® technology. Slides were stained automatically with a modified Romanowsky stain and with a supravital stain on a separate slide for analysis of reticulocytes. These stains were modified for high-speed application and provide consistency across all cobas m 511 systems. The system then digitally identified and counted the red blood cells (RBCs), WBCs, platelets (PLTs), and
NRBCs on the microscope slide using low-magnification (×10) multispectral imaging. Randomized locations of between 600 and 700
WBCs were recorded, imaged using high-magnification (×50) multispectral imaging, and an automated WBC differential performed using computer algorithms. Unclassified cells that did not fall into the five normal WBC types were flagged and presented in the viewing station for review. RBC and PLT indices were also measured during the high-magnification analysis.
The cobas m 511 system was evaluated at two European 
| Samples and evaluation protocol
Samples were comprised of residual whole blood clinical samples (n = 2546 in total) and fresh whole blood samples from healthy volunteers (n = 480 in total). Sample totals were obtained from collecting approximate equal proportions from the four clinical sites.
Residual whole blood samples were collected randomly or selected based on specific laboratory results. These samples were provided with birth year, sex, sample draw time, and laboratory results from the comparative instrument, when required. Fresh whole blood samples were collected from healthy volunteers after they had signed an informed consent and completed a questionnaire to verify health status. These volunteers were males and females aged ≥18 years, and sample collection was in accordance with the Clinical Laboratory Standards Institute (CLSI) EP28-A3c guideline. 8 All samples were collected in standard K2-EDTA collection tubes (Sarstedt, Nümbrecht, Germany; Becton Dickinson, Franklin Lakes, NJ, USA) and processed within 8 hours of venipuncture. Standard blood smears were prepared according to site-specific methods within 2 hours of running on automated analyzers. Dedicated study coordinators at each site performed all instrument-related analytical evaluations and managed the image and slide reviews by study technologists.
The study protocol was approved by each site's Ethics Committee or Institutional Review Board.
The analytical performance assessments of the cobas m 511 system comprised: whole blood repeatability, reproducibility using DigiMAC3 ® controls (Roche), carryover, mode-to-mode comparison, morphology, WBC clinical sensitivity, and method comparison (Table 1 ).
| Whole blood repeatability
Repeatability evaluated within-run precision using whole blood samples according to the CLSI EP05-A3 guideline 9 and CLSI H26-A2
standard. 10 The repeatability of reticulocyte (RET) related parameters (%RET, #RET, RET-HGB) was not evaluated.
Overall, 144 residual whole blood samples were selected for WBC, RBC, hemoglobin (HGB), and PLT parameters at targeted low, middle, and high ranges generally encountered in the laboratory.
Forty-eight samples at medical decision levels for anemia (n = 12), thrombocytopenia (n = 12), severe leukopenia (n = 12), and elevated NRBCs (n = 12) were also evaluated. Samples were processed 31 consecutive times over 35 minutes on the cobas m 511 system. The mean, standard deviation (SD), and coefficient of variance (%CV)
were calculated for each sample separately, and the range and mean of the samples means, and repeatability derived by a mixed model analysis, were determined for each parameter.
| Reproducibility
Reproducibility of results was determined using three levels of DigiMAC3 ® quality control materials in a multiday assessment according to CLSI EP05-A3 guideline. 9 The same lot was used at each site to minimize lot-to-lot bias.
The assessment used a 4 × 5 × 2 × 3 design, that is four clinical sites, 5 days, two runs per day, and three replicates per run. Within-run precision (repeatability), between-run precision (same day), betweenday precision, between-laboratory precision, and reproducibility (total precision) were calculated. For each parameter and control level, the mean, SD, and %CV of the components of precision were determined (with 95% CI of the SD and %CV for repeatability and reproducibility).
Low SD and %CV results are indicative of good reproducibility.
| Carryover
Carryover All reportable parameters HGB, hemoglobin; PLT, platelets; RBC, red blood cell; WBC, white blood cell. were excluded from this analysis due to very low prevalence.
| Mode-to-mode comparison

| Morphology
Cellular morphology was assessed to ensure that morphological characteristics that were present on blood smears could be identi- compared with a manual 400-cell reference differential (combined from two technologists). The goal was to determine whether the cobas m 511 automated WBC differential, system messages, cobas m 511 images, and cobas m 511 slides generated results that were consistent with the manual microscopy. The primary review mechanism for the cobas m 511 system is the images; however, the cobas m 511 slides were also studied to ensure they could be used, if needed, for additional review by the laboratory.
Two qualified technologists at each site each reviewed one-half of the cobas m 511 images and cobas m 511 slides for WBC differentials.
Three corresponding blood smears per sample were also produced for the reference differential. It was expected that distributional and morphologic abnormalities seen on the cobas m 511 system should also be present on the corresponding reference 400-cell reference differential. The sensitivity, specificity, and efficiency of the different cobas m 511 system modalities compared with the 400-cell reference differential were calculated.
| Method comparison
Method comparison assessed correlation and bias of results obtained on the cobas m 511 system vs the Sysmex XN-10 or XN-20 automated hematology analyzer. Sample processing was randomized and occurred over 2 weeks to minimize sampling bias and to capture the routine populations of each laboratory. From all sites combined, 1591 residual whole blood samples were analyzed.
Correlation and bias between results were determined according to CLSI EP09-A3 guideline 11 using either a Passing-Bablok or Deming regression model as described for the mode-to-mode comparison. were used in the statistical analysis. If one or more individual parameters were considered invalid, the remaining valid parameters were reported and included in the dataset. All results and conclusions are from combined data from all four clinical sites unless stated otherwise.
| Data analysis and statistics
| RE SULTS
| Whole blood repeatability
The cobas m 511 system demonstrated high repeatability for most of the testing parameters (Table 2) , with relatively lower repeatability seen for basophil and NRBC counts. The reference method was a 400-cell manual differential derived from combined results of two technologists at each site. Data are from all sites combined. Table S1 shows the results of various components of precision calculated using three levels of DigiMAC3 ® controls. The SD or %CV results for all parameters indicate that the cobas m 511 system produces reproducible results.
TA B L E 2 Whole blood repeatability results
| Reproducibility
| Carryover
The mean percent carryover was below 0.01% for WBCs, RBCs, and PLTs and below 0.001% for blasts indicating virtually no carryover between samples, including blast cases.
| Mode-to-mode comparison
The results of the mode-to-mode comparison demonstrated satisfactory bias and correlation with Pearson's R values ranging from 0.674 to 0.997 for CBC and differential parameters (Table S2; %NRBCs were excluded from this analysis).
| Morphology
The overall percent agreement between the results obtained with the viewing station and the gold standard manual microscopy 100-cell reference differential was 95.6% for WBC, RBC, and PLT characteristics. For cobas m 511 slide microscopy, the overall percent agreement was 95.7%. In general, this demonstrates that the results from the cobas m 511 images and slides compare well with results obtained by technologists in routine practice using a blood smear.
| WBC clinical sensitivity
The cobas m 511 system assessments correlated well with the manual 400-cell reference differential method for detecting abnormal distribution of WBCs and the presence of morphological abnormalities. The sensitivity, specificity, and efficiency results vs the gold standard manual differential method were 94.4%, 74.6%, and 90.7%, respectively, for the automated differential and 95.9%, 73.3%, and 92.7%, respectively, for the manual image review on the viewing station (Table 3) . Slightly lower values were seen for cobas m 511 slides vs the reference method. A lower efficiency was observed for monocytes with all cobas m 511 system modalities (Table S3 ).
The manual differential count identified 76 samples with blasts, reference differential count as reference revealed an overall sensitivity and specificity of 92.9% and 96.8%, respectively (Table 3) .
In particular, all 76 blast-positive samples identified by manual differential count were correctly flagged by the cobas m 511 system.
Five other samples were flagged for the presence of blast cells by the cobas m 511 system that were not detected by manual differential count. The system also correctly flagged 13 of 14 samples with variant lymphocytes detected with manual differential count and flagged a further eight samples that were not verified by microscopy.
| Method comparison
Interinstrument comparison between the cobas m 511 and Sysmex 
| D ISCUSS I ON
The cobas m 511 system is the first fully automated slide-based hematology analyzer that uses digital microscopy to provide numerical and to provide consistent and precise results in routine diagnostic settings over time regardless of location, system, and operator.
All cobas m 511 system modalities, automated counts, automated system flags, review on viewing station, and review using cobas m 511 slides, were validated in WBC clinical sensitivity testing as compared to manual microscopy as standard method. The overall agreement between cobas m 511 automated analysis of neutrophil, lymphocyte, and eosinophil counts with microscopy was high.
This indicates that the cobas m 511 system delivers reliable results for these cell types when compared to the 400-cell reference differential, thereby automating much of the blood analysis process.
Comparable results were also observed in previous studies comparing differential blood counts from flow cytometry-based hematology analyzers with microscopy. 3, 13, 14 The lower correlation of basophil counts between automated and manual counts is largely due to statistical uncertainty, due to low basophil counts in normal samples and the lack of samples with higher basophil counts. Poor correlations between basophil counts are seen in most comparative studies of impedance and flow-based analyzers. 3, 13, 14 The main function of routine hematology analyzers is to correctly identify samples containing pathological cell types with a need for further evaluation. A key requirement is that the rate of false-positive flags is low to reduce unnecessary reviews. The automated flagging of samples for the presence of blast cells and variant lymphocytes with the cobas m 511 system was very good, especially considering the cobas m 511 system is a first-of-a-kind instrument.
The system identified samples with blast cells detected by microscopy with a sensitivity of 100% and a specificity of 99%. Recent publications show significant differences for blast cell flagging quality between different hematology analyzers with sensitivities ranging from 97% to 100% for the Sysmex XN system to 72% for the Beckman DxH 800 system and specificities of 93%-98%. (37.0%, Table 2 ), likely reflecting how the technologists defined left shift using manual microscopy (based on band counts), and the typically poor inter-and intraobserver reproducibility.
16
The widely used Sysmex XN hematology analyzer was selected for interinstrument comparison for automatically generated numerical and differential results. 3, [13] [14] [15] Bracco coordinated the running of the study. All authors drafted and critically revised the paper and approved the final version.
